NOMINATING AGREEMENTNominating Agreement • August 19th, 2019 • IGM Biosciences, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 19th, 2019 Company Industry JurisdictionTHIS NOMINATING AGREEMENT (this “Agreement”), dated as of June 28, 2019, is by and between IGM Biosciences, Inc., a Delaware corporation (the “Company”) Redmile Biopharma Investments II, L.P., RAF, L.P. and Redmile Strategic Master Fund, LP (each an “Investor” and together, the “Investors”).
NOMINATING AGREEMENTNominating Agreement • August 9th, 2019 • IGM Biosciences, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 9th, 2019 Company Industry JurisdictionTHIS NOMINATING AGREEMENT (this “Agreement”), dated as of June 28, 2019, is by and between IGM Biosciences, Inc., a Delaware corporation (the “Company”) Redmile Biopharma Investments II, L.P., RAF, L.P. and Redmile Strategic Master Fund, LP (each an “Investor” and together, the “Investors”).